People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, Business Services, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Akari Therapeutics Plc | — | Biotechnology | Series C | $140.5M | $34.0M | 2012 |
| Artelon, Inc. | — | Biotechnology | Series B | $20.0M | $230.5M | 2023 |
| Pluto Immunotherapeutics, Inc. | — | Biotechnology | Seed | $5.0M | $54.2M | 2020 |
| Clearspire Service Co LLC | — | Business Services | Pre-Seed | $1.0M | $31.6M | 2009 |
| Wide Awake VR, Inc. | — | Other Technology | Pre-Seed | $250K | $4.8M | 2021 |
MARK COHEN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside MARK COHEN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carter Meyer | 1 | 14 |
| Kirk Nielsen | 1 | 13 |
| Hoyoung Huh | 1 | 7 |
| Samir Patel | 1 | 7 |
| David Sidransky | 1 | 7 |
| David Wheeler | 1 | 6 |
| JAMES HILL | 1 | 6 |
| Donald Williams | 1 | 4 |
| Wendy DiCicco | 1 | 4 |
| Yuval Cohen | 1 | 4 |
| DOV ELEFANT | 1 | 3 |
| Johnson Lau | 1 | 3 |
| Gary Burbach | 1 | 3 |
| Aaron Smith | 1 | 3 |
| Wa'el Hashad | 1 | 2 |
| Michael Grissinger | 1 | 2 |
| Allan Shaw | 1 | 2 |
| Robert Doman | 1 | 2 |
| Gur Roshwalb | 1 | 2 |
| Fredric Price | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.